T-helper-1-cell cytokines drive cancer into senescence
2013 · Nature · 705 citations
https://doi.org/10.1038/nature11824
F
Friedegund Meier
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
484
Papers
17.9K
Citations
70
h-index
207
i10-index
Friedegund Meier is an academic researcher from University Hospital Carl Gustav Carus. The author has contributed to research in topics: Cutaneous Melanoma Detection and Management & Melanoma and MAPK Pathways & Cancer Immunotherapy and Biomarkers. The author has an h-index of 70, co-authored 412 publications.
ORCID: 0000-0003-4340-9706Papers by this author
worksDeterminants of survival in patients with brain metastases from cutaneous melanoma
2010 · British Journal of Cancer · 159 citations
https://doi.org/10.1038/sj.bjc.6605622
Combining CNN-based histologic whole slide image analysis and patient data to improve skin cancer classification
2021 · European Journal of Cancer · 105 citations
https://doi.org/10.1016/j.ejca.2021.02.032
Hematological immune related adverse events after treatment with immune checkpoint inhibitors
2021 · European Journal of Cancer · 86 citations
https://doi.org/10.1016/j.ejca.2021.01.013
The Farnesyl Transferase Inhibitor Lonafarnib Inhibits mTOR Signaling and Enforces Sorafenib-Induced Apoptosis in Melanoma Cells
2010 · Journal of Investigative Dermatology · 66 citations
https://doi.org/10.1038/jid.2010.297
Adjuvant immunotherapy with nivolumab versus observation in completely resected Merkel cell carcinoma (ADMEC-O): disease-free survival results from a randomised, open-label, phase 2 trial
2023 · The Lancet · 63 citations
https://doi.org/10.1016/s0140-6736(23)00769-9
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat